News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,303 Results
Type
Article (331)
Press Release (9972)
Section
Business (2607)
Deals (450)
Drug Delivery (1)
Drug Development (2491)
FDA (397)
Job Trends (370)
News (5847)
Policy (463)
Tag
Academia (26)
Allergies (3)
Alliances (554)
Alzheimer's disease (7)
Antibody-drug conjugate (ADC) (2)
Approvals (407)
Autoimmune disease (2)
Bankruptcy (3)
Best Places to Work (383)
Biosimilars (1)
Bladder cancer (8)
Breast cancer (3)
Cancer (51)
Cardiovascular disease (2)
Cell therapy (8)
Cervical cancer (3)
Clinical research (2216)
Collaboration (17)
Compensation (9)
COVID-19 (9)
CRISPR (1)
C-suite (6)
Data (96)
Diabetes (7)
Diagnostics (33)
Duchenne muscular dystrophy (2)
Earnings (1185)
Events (1647)
Executive appointments (12)
FDA (441)
Funding (7)
Gene editing (2)
Gene therapy (17)
GLP-1 (8)
Government (54)
Grass and pollen (1)
Healthcare (268)
Immunology and inflammation (2)
Infectious disease (10)
Influenza (1)
Intellectual property (2)
IPO (258)
Job creations (20)
Layoffs (5)
Legal (34)
Liver cancer (3)
Lung cancer (17)
Manufacturing (1)
Medical device (174)
Medtech (174)
Mergers & acquisitions (208)
Metabolic disorders (8)
Multiple sclerosis (1)
Neuroscience (9)
NextGen: Class of 2025 (55)
Non-profit (16)
Northern California (45)
Now hiring (1)
Ovarian cancer (5)
Pain (8)
Patents (4)
Patient recruitment (5)
People (823)
Phase I (508)
Phase II (981)
Phase III (922)
Pipeline (34)
Podcasts (1)
Policy (1)
Postmarket research (60)
Preclinical (184)
Prostate cancer (1)
Radiopharmaceuticals (4)
Rare diseases (2)
Real estate (22)
Regulatory (441)
Reports (1)
Research institute (20)
Series A (1)
Series B (1)
Sickle cell disease (1)
Southern California (43)
Startups (60)
The Weekly (1)
United States (457)
Vaccines (5)
Weight loss (1)
Date
Today (5)
Last 7 days (19)
Last 30 days (71)
Last 365 days (811)
2025 (187)
2024 (853)
2023 (974)
2022 (1129)
2021 (1264)
2020 (941)
2019 (686)
2018 (516)
2017 (557)
2016 (497)
2015 (586)
2014 (379)
2013 (223)
2012 (204)
2011 (221)
2010 (238)
Location
Africa (2)
Arizona (1)
Asia (488)
Australia (75)
California (103)
Canada (14)
China (6)
Connecticut (2)
Delaware (8)
Europe (1362)
Florida (6)
Georgia (19)
Idaho (5)
Illinois (8)
India (1)
Indiana (2)
Japan (6)
Kentucky (1)
Maryland (13)
Massachusetts (119)
Michigan (5)
Minnesota (2)
New Jersey (48)
New York (42)
North Carolina (27)
Northern California (45)
Ohio (2)
Pennsylvania (27)
Rhode Island (1)
South America (5)
Southern California (43)
Tennessee (6)
Texas (9)
Virginia (1)
Washington State (10)
10,303 Results for "ocular therapeutix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ocular Therapeutix™ to Participate in Two Investor Conferences in April 2025
April 1, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ to Present at Two Investor Conferences in March 2025
February 26, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
March 4, 2025
·
22 min read
Press Releases
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025
February 24, 2025
·
1 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025
March 10, 2025
·
2 min read
Press Releases
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
February 3, 2025
·
2 min read
Genetown
Ocular Therapeutix® to Host Investor Day on June 13, 2024
Ocular Therapeutix, Inc. will host an Investor Day on Thursday, June 13, 2024.
June 5, 2024
·
5 min read
Press Releases
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
January 14, 2025
·
13 min read
Press Releases
Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences
November 26, 2024
·
2 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 17, 2025
January 20, 2025
·
2 min read
1 of 1,031
Next
